These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1001831)
21. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines]. Luick K; Gottschaldt J; Schulze F; Werner E; Erler W; Borrmann E Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370 [TBL] [Abstract][Full Text] [Related]
22. Immunoelectrophoresis in quality control of veterinary clostridial products. White VJ; Sojka MG Dev Biol Stand; 1986; 64():119-27. PubMed ID: 3792642 [TBL] [Abstract][Full Text] [Related]
23. Potency testing Clostridium novyi-containing bacterins: comparison of immunologic response in guinea pigs and sheep. Macheak ME; Claus KD; Maloy SE Am J Vet Res; 1972 Jun; 33(6):1201-8. PubMed ID: 5022400 [No Abstract] [Full Text] [Related]
24. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines]. Cussler K; Borrmann E; Werner E Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):172-7. PubMed ID: 11998369 [TBL] [Abstract][Full Text] [Related]
25. A mouse model to estimate the potency of the diphtheria component in combined vaccines. Kreeftenberg JG; van der Gun J; Marsman FR; van Asten JA; Sekhuis VM; Hendriksen CF Dev Biol Stand; 1986; 64():21-4. PubMed ID: 2878846 [TBL] [Abstract][Full Text] [Related]
26. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids. Gupta RK; Siber GR Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950 [TBL] [Abstract][Full Text] [Related]
27. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines. Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine. Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208 [TBL] [Abstract][Full Text] [Related]
29. The development of an enzyme-linked immunosorbent assay for measuring the potency of vaccines containing Clostridium chauvoei antigens. Crichton R; Solomon J; Barton AM Biologicals; 1990 Jan; 18(1):49-54. PubMed ID: 2317354 [TBL] [Abstract][Full Text] [Related]
30. [Trials of immunostimulation of an antitoxic response with levamisole in the immunization of sheep with a combined clostridial vaccine]. Bineva I; Peĭchev B; Marinov MI Vet Med Nauki; 1986; 23(4):35-8. PubMed ID: 2874649 [TBL] [Abstract][Full Text] [Related]
31. Inflammatory response to clostridial vaccines in feedlot cattle. Stokka GL; Edwards AJ; Spire MF; Brandt RT; Smith JE J Am Vet Med Assoc; 1994 Feb; 204(3):415-9. PubMed ID: 8150699 [TBL] [Abstract][Full Text] [Related]
32. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines. Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397 [TBL] [Abstract][Full Text] [Related]
33. Experimental clostridial oil emulsion vaccines. Thomson RO; Batty I Bull Off Int Epizoot; 1967; 67(11):1569-81. PubMed ID: 5619370 [No Abstract] [Full Text] [Related]
34. Effective immunization of lambs against enterotoxaemia. Cameron CM Onderstepoort J Vet Res; 1980 Dec; 47(4):287-9. PubMed ID: 7231926 [TBL] [Abstract][Full Text] [Related]
35. Proposals for quality control methods of bacterial vaccines for immunostimulation. I. General considerations. Sirks JL; Ruitenberg EJ Dev Biol Stand; 1977 Apr 13-15; 38():87-9. PubMed ID: 608552 [TBL] [Abstract][Full Text] [Related]
36. [Mixed vaccine against bacterial anthrax and symptomatic anthrax]. Blancou JM Rev Elev Med Vet Pays Trop; 1974; 27(2):183-7. PubMed ID: 4219888 [No Abstract] [Full Text] [Related]
37. Prospects for the refinement and reduction of animal usage in the potency testing of Cl. chauvoei vaccines. Tilleray JH; Knight PA Dev Biol Stand; 1986; 64():111-8. PubMed ID: 3792641 [TBL] [Abstract][Full Text] [Related]
38. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2. Sesardic D; Winsnes R; Rigsby P; Gaines-Das R Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100 [TBL] [Abstract][Full Text] [Related]
39. Direct-challenge potency test for bacterins containing Clostridium septicum. Choman BR; Cooper MS; Martini FV Am J Vet Res; 1968 Mar; 29(3):679-83. PubMed ID: 5637928 [No Abstract] [Full Text] [Related]